To evaluate the moisturization of Gel.
- Registration Number
- CTRI/2024/02/062510
- Lead Sponsor
- Piramal Pharma Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Gender: Male or Female 18 to 40
Subjects willing to give written informed consent
Women of child bearing potential must have a negative urine pregnancy test prior to study entry.
Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events.
Are willing to avoid prolonged exposure of the treatment area
To ultraviolet radiation (natural or artificial) for the duration of the study.
Subjects who are pregnant, breast-feeding, or planning to become pregnant during the study.
Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years, or any other confounding skin condition.
Have open sores or open lesions in the treatment area(s).
Have any condition that, in the opinion of the investigator, would confound the safety or efficacy assessments of the product.
Have participated in any interventional clinical trial in the previous 90 days.
Have a known sensitivity to any of the constituents of the test product
Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including corticosteroids.
Have not skin related issues
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in MoistureTimepoint: Day 1
- Secondary Outcome Measures
Name Time Method ot ApplicableTimepoint: Not Applicable